CITIGROUP INC - OVID THERAPEUTICS INC ownership

OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 58 filers reported holding OVID THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of OVID THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$111
-99.8%
29
-99.8%
0.00%
Q2 2023$58,246
+2431.3%
17,758
+1335.6%
0.00%
Q4 2022$2,301
+15.0%
1,237
+3.6%
0.00%
Q3 2022$2,000
-33.3%
1,194
-16.6%
0.00%
Q2 2022$3,000
-40.0%
1,432
-14.3%
0.00%
Q1 2022$5,000
-28.6%
1,671
-18.8%
0.00%
Q4 2021$7,000
-41.7%
2,058
-42.1%
0.00%
Q3 2021$12,000
-25.0%
3,555
-13.5%
0.00%
Q2 2021$16,000
-11.1%
4,111
-5.7%
0.00%
Q1 2021$18,000
-25.0%
4,361
-58.5%
0.00%
Q4 2020$24,000
-33.3%
10,507
+66.5%
0.00%
Q3 2020$36,000
-16.3%
6,312
+8.2%
0.00%
Q2 2020$43,000
+186.7%
5,833
+14.1%
0.00%
Q1 2020$15,000
-99.3%
5,113
-99.0%
0.00%
-100.0%
Q4 2019$2,081,000
+41520.0%
501,462
+33645.8%
0.00%
Q3 2019$5,000
+25.0%
1,486
-25.1%
0.00%
Q2 2019$4,000
-42.9%
1,985
-43.4%
0.00%
Q1 2019$7,000
-22.2%
3,504
+0.7%
0.00%
Q4 2018$9,000
-55.0%
3,480
-3.7%
0.00%
Q3 2018$20,000
+100.0%
3,615
+137.5%
0.00%
Q1 2018$10,000
+100.0%
1,522
+196.7%
0.00%
Q4 2017$5,000
-98.3%
513
-98.2%
0.00%
Q2 2017$301,00028,6290.00%
Other shareholders
OVID THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
TLS Advisors LLC 1,380,346$3,51618.08%
Madison Avenue Partners, LP 3,104,603$8,009,8761.72%
BVF INC/IL 6,851,051$17,675,7120.65%
CHI Advisors LLC 864,822$2,231,2410.59%
EcoR1 Capital, LLC 6,117,400$15,782,8920.51%
Rubric Capital Management LP 7,001,124$18,062,9000.47%
Artal Group S.A. 2,500,000$6,4500.38%
Tejara Capital Ltd 118,791$306,4810.16%
DCF Advisers, LLC 68,264$176,1200.11%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 827,580$2,135,1560.06%
View complete list of OVID THERAPEUTICS INC shareholders